CONVERTING ENZYME-INHIBITORS IN HEMODIALYSIS

[1] CONVERSION OF ANGIOTENSIN 1 TO ANGIOTENSIN 2 BY CELL-FREE EXTRACTS OF DOG LUNG [J]. NATURE, 1968, 220 (5170) : 919 - &

[2] 3 NEW LONG-ACTING CONVERTING-ENZYME INHIBITORS - RELATIONSHIP BETWEEN PLASMA CONVERTING-ENZYME ACTIVITY AND RESPONSE TO ANGIOTENSIN-I [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (05) : 665 - 670

[3] BRENNER BM, 1981, KIDNEY, V2, P781

[4] BRUNNER HR, 1979, PHARM CLIN USE ANGIO, P57

[5] A BRADYKININ-POTENTIATING FACTOR ( BPF ) PRESENT IN VENOM OF BOTHROPS JARARACA [J]. BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1965, 24 (01): : 163 - &

[6] ANGIOTENSIN CONVERTING-ENZYME INHIBITOR TO IDENTIFY AND TREAT VASOCONSTRICTOR AND VOLUME FACTORS IN HYPERTENSIVE PATIENTS [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (16) : 817 - 821

[7] GAVRAS H, 1981, LANCET, V2, P543

[8] GOULD AB, 1973, LAB INVEST, V28, P719

[9] HIRAKATA H, 1981, CLIN NEPHROL, V16, P321

[10] HOORNTJE SJ, 1980, ACTA MED SCAND, V208, P325

[1] CONVERSION OF ANGIOTENSIN 1 TO ANGIOTENSIN 2 BY CELL-FREE EXTRACTS OF DOG LUNG [J]. NATURE, 1968, 220 (5170) : 919 - &

[2] 3 NEW LONG-ACTING CONVERTING-ENZYME INHIBITORS - RELATIONSHIP BETWEEN PLASMA CONVERTING-ENZYME ACTIVITY AND RESPONSE TO ANGIOTENSIN-I [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (05) : 665 - 670

[3] BRENNER BM, 1981, KIDNEY, V2, P781

[4] BRUNNER HR, 1979, PHARM CLIN USE ANGIO, P57

[5] A BRADYKININ-POTENTIATING FACTOR ( BPF ) PRESENT IN VENOM OF BOTHROPS JARARACA [J]. BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1965, 24 (01): : 163 - &

[6] ANGIOTENSIN CONVERTING-ENZYME INHIBITOR TO IDENTIFY AND TREAT VASOCONSTRICTOR AND VOLUME FACTORS IN HYPERTENSIVE PATIENTS [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (16) : 817 - 821

[7] GAVRAS H, 1981, LANCET, V2, P543

[8] GOULD AB, 1973, LAB INVEST, V28, P719

[9] HIRAKATA H, 1981, CLIN NEPHROL, V16, P321

[10] HOORNTJE SJ, 1980, ACTA MED SCAND, V208, P325